Unknown

Dataset Information

In vivo assessment of OXPHOS capacity using 3 T CrCEST MRI in Friedreich's ataxia.


ABSTRACT:

Background

Friedreich's ataxia (FRDA) is a neurodegenerative disease caused by decreased expression of frataxin, a protein involved in many cellular metabolic processes, including mitochondrial oxidative phosphorylation (OXPHOS). Our objective was to assess skeletal muscle oxidative metabolism in vivo in adults with FRDA as compared to adults without FRDA using chemical exchange saturation transfer (CrCEST) MRI, which measures free creatine (Cr) over time following an in-magnet plantar flexion exercise.

Methods

Participants included adults with FRDA (n = 11) and healthy adults (n = 25). All underwent 3-Tesla CrCEST MRI of the calf before and after in-scanner plantar flexion exercise. Participants also underwent whole-body dual-energy X-ray absorptiometry (DXA) scans to measu

SUBMITTER: Schur GM 

PROVIDER: S-EPMC9010488 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature